Physician

Adam Joseph Pettigrew, M.D.

According to 2025 Medicare claims, Adam Pettigrew, M.D. (NPI: 1902148539) practices internal medicine in the Marietta, GA market, with the plurality of this provider's patient population coming from Cobb, GA. This provider's primary affiliated billing organization is INFECTIOUS DISEASE SERVICES OF GEORGIA PC (NPI: 1831236728; TIN: 73-1711534) and primary practice location at 30114-5257.

Pettigrew's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 406 traditional Medicare patients, billed 247,241 HCPCS/CPT codes, and received $835,263 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 1,121 prescription claims across 240 beneficiaries totaling $286,814 in drug costs, led by Genvoya (Elviteg/Cob/Emtri/Tenof Alafen). 2023 DME data shows 24 claims. Open Payments data shows 7 records totaling $182. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $46,877 to $835,263. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $4,346 and ending at $286,814. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $4,201 and ending at $7,632.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	122	10,131	$46,877
2019	349	49,210	$240,735
2020	399	131,548	$489,742
2021	408	129,672	$599,586
2022	443	119,188	$674,606
2023	528	99,733	$835,751
2024	406	247,241	$835,263

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	13	55	$4,346
2016	18	119	$68,853
2017	22	437	$349,099
2018	59	427	$350,552
2019	111	389	$110,240
2020	154	643	$179,601
2021	192	771	$265,049
2022	199	898	$234,283
2023	222	968	$311,487
2024	240	1,121	$286,814

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	90	$4,456
2022	N/R	36	$1,924
2023	N/R	24	$2,518
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	69	74	$131
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	127	134	$100
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	155	416	$97
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	125	299	$67
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	159	356	$61

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Genvoya	Elviteg/Cob/Emtri/Tenof Alafen	12	360	$46,951
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	12	360	$46,819
Daptomycin	Daptomycin	29	198	$25,529
Ertapenem	Ertapenem Sodium	28	188	$18,437
Fosfomycin Tromethamine	Fosfomycin Tromethamine	37	892	$10,659

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	7	$182	Gilead Sciences, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adam Joseph Pettigrew, M.D.?

Tedicare shows public-source Medicare data for Adam Joseph Pettigrew, M.D. (NPI 1902148539), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam Joseph Pettigrew, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Adam Joseph Pettigrew, M.D.?

Adam Joseph Pettigrew, M.D. is linked to INFECTIOUS DISEASE SERVICES OF GEORGIA PC (billing NPI 1831236728) in the available physician profile data.

Does Adam Joseph Pettigrew, M.D. have Open Payments data?

Adam Joseph Pettigrew, M.D. has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.